gatifloxacin has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, RE | 1 |
| Hotta, H; Kunishima, Y; Kuroki, Y; Matsukawa, M; Mitsuzawa, H; Nishitani, C; Sano, H; Shibata, K; Shimizu, T; Takahashi, S; Takeyama, K; Tsukamoto, T | 1 |
2 other study(ies) available for gatifloxacin and interleukin-8
| Article | Year |
|---|---|
Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.
Topics: Aza Compounds; Cell Line; Cell Movement; Chemokine CCL2; Chlamydia Infections; Chlamydophila pneumoniae; Endothelium, Vascular; Fluoroquinolones; Gatifloxacin; Humans; Interleukin-8; Monocytes; Moxifloxacin; Neutrophils; Ofloxacin; Phagocytosis; Quinolines; Stimulation, Chemical; Tumor Necrosis Factor-alpha | 2005 |
The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3.
Topics: Anti-Infective Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Fluoroquinolones; Gatifloxacin; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Luciferases; Macrophages; Male; Monocytes; NF-kappa B; Peptidoglycan; Phorbol Esters; Promoter Regions, Genetic; Prostatic Neoplasms; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha | 2007 |